BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3537664)

  • 1. [Treatment of stress-induced angina pectoris and chronic heart failure with molsidomine].
    Beyerle A; Rudolph W
    Med Klin (Munich); 1986 Jan; 81(2):41-4. PubMed ID: 3537664
    [No Abstract]   [Full Text] [Related]  

  • 2. [The importance of Lopion (molsidomine) in the therapy of myocardial ischemia and angina pectoris].
    Trifunović S; Pavlović K
    Med Pregl; 1987; 40(1-2):17-21. PubMed ID: 3657717
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of dilazep in the treatment of coronary insufficiency. A randomized and double-blind study on subjects with stable, exertion angina].
    Romano M; De Caprio L; Scarafile P; Carlomagno A; Meccariello P; Condorelli M
    Minerva Cardioangiol; 1980; 28(7-8):489-94. PubMed ID: 7005711
    [No Abstract]   [Full Text] [Related]  

  • 4. [Duration of the antianginal effect of oral molsidomine in exertion angina. Double-blind, crossed and randomized study].
    Bordes P; Gimeno JV; Olagüe J; Ferrer J; Hernández M; Algarra F
    Rev Esp Cardiol; 1986; 39(2):138-42. PubMed ID: 3523649
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gallopamil and molsidomine in patients with coronary heart disease. A comparative study].
    Zebe H
    Fortschr Med; 1989 Feb; 107(5):134-8. PubMed ID: 2651251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antianginal effect of molsidomine in prolonged oral therapy. A double blind, crossover, randomized study.
    Baudry C
    Acta Cardiol; 1982; 37(1):23-30. PubMed ID: 7044013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of molsidomine in exertion angina pectoris: double-blind, randomized and placebo-controlled study].
    Scuri PM; Gavazzi A; Falcone C; Specchia G; Montemartini C
    Cardiologia; 1987 Mar; 32(3):271-6. PubMed ID: 3607796
    [No Abstract]   [Full Text] [Related]  

  • 8. Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
    Balestrini AE; Menzio AC; Cabral R; Feldman R; Mercogliano C; Flichtentrei D; Albera HP; Vazquez A
    Eur J Clin Pharmacol; 1984; 27(1):1-5. PubMed ID: 6386486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effectiveness of molsidomine in patients with exercise-induced angina pectoris].
    Sinkiewicz W; Dziedziczko A
    Pol Tyg Lek; 1993 Jan 18-25; 48(3-4):80-2. PubMed ID: 8361895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of a new antianginal drug: droprenylamine].
    Rengo F; Trimarco B; Volpe M; Ricciadelli B; Morrone G; De Simone A; Condorelli M
    G Ital Cardiol; 1980; 10(4):473-5. PubMed ID: 7002693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of myocardial ischemia with molsidomine].
    Dirschinger J; Beyerle A; Rudolph W
    Med Klin (Munich); 1990 Mar; 85(3):141-4. PubMed ID: 2186260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molsidomine: evaluation of a single dose using the exercise test].
    Ruano J; Zueco J; Colman T; López C; Pajarón A
    Rev Esp Cardiol; 1985; 38(2):93-7. PubMed ID: 3890039
    [No Abstract]   [Full Text] [Related]  

  • 14. [Varying response to nifedipine during treatment of stable exertional angina pectoris: results of a double-blind, randomized, cross-over, placebo-controlled study (author's transl)].
    Brügmann U; Blasini R; Goebel G; Mannes A; Dirschinger J; Rudolph W
    Herz; 1982 Apr; 7(2):117-25. PubMed ID: 7044932
    [No Abstract]   [Full Text] [Related]  

  • 15. [Problems in long-term therapy of coronary heart disease: pharmacotherapy].
    Gilfrich HJ
    Med Klin (Munich); 1987 Jan; 1():29-32. PubMed ID: 3106752
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biorhythm influence on the course of ischemic heart disease during combined treatment with molsidomine and anaprilin].
    Vakaliuk IP
    Ter Arkh; 1986; 58(12):49-50. PubMed ID: 3824212
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of bunitrolol (Ko 1366) in the therapy of angina pectoris].
    Maranhão MF; Rocha SW; Lopes M; Toledo MT; Furlan L; Hilú M; Pereira da Cunha G
    Arq Bras Cardiol; 1978 Apr; 31(2):143-7. PubMed ID: 28715
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
    MMW Fortschr Med; 2011 Feb; 153(7):44-5. PubMed ID: 21648143
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.